Medical Transcription Billing, Corp. (MTBC) Given Daily Coverage Optimism Score of 0.11

Press coverage about Medical Transcription Billing, Corp. (NASDAQ:MTBC) has trended somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Medical Transcription Billing, Corp. earned a news impact score of 0.11 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 45.2527899367362 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

Several research firms have recently commented on MTBC. Zacks Investment Research raised shares of Medical Transcription Billing, Corp. from a “sell” rating to a “hold” rating in a research note on Wednesday, October 18th. Chardan Capital raised their price objective on shares of Medical Transcription Billing, Corp. from $2.25 to $2.75 and gave the company a “buy” rating in a research note on Tuesday. Finally, ValuEngine upgraded shares of Medical Transcription Billing, Corp. from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd.

Shares of Medical Transcription Billing, Corp. (NASDAQ MTBC) traded down $0.07 during trading on Tuesday, reaching $2.47. 502,200 shares of the company were exchanged, compared to its average volume of 1,222,909. Medical Transcription Billing, Corp. has a one year low of $0.29 and a one year high of $5.44. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.01.

In related news, President Stephen Andrew Snyder sold 50,000 shares of Medical Transcription Billing, Corp. stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $3.18, for a total value of $159,000.00. Following the completion of the transaction, the president now owns 106,000 shares in the company, valued at $337,080. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 53.50% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Medical Transcription Billing, Corp. (MTBC) Given Daily Coverage Optimism Score of 0.11” was first posted by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.thestockobserver.com/2017/11/14/medical-transcription-billing-corp-mtbc-given-daily-coverage-optimism-score-of-0-11.html.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Insider Buying and Selling by Quarter for Medical Transcription Billing, Corp. (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply